Indo Us Bio-Tech Ltd
P&L
Quarterly Standalone
vs Q4 FY25
Indo Us Bio-Tech Ltd. Reports Q1 2025 Financial Results with Net Profit of INR 626.24 Million
12 Aug 2025 · 12 Aug 2025, 02:39 pm
Summary
Indo Us Bio-Tech Ltd. has reported their Q1 2025 financial results with a net profit of INR 626.24 Million. The company's revenue from operations is INR 10,383.64 Million, with total income from operations at INR 10,402.04 Million. The company's net profit for the year ended 31st March 2025 is INR 1,627.26 Million. There were no investor complaints pending or received during the period under review.
Key Highlights
- 1
Revenue from operations: INR 10,383.64 Million
- 2
Net profit for Q1 2025: INR 626.24 Million
- 3
Net profit for the year ended 31st March 2025: INR 1,627.26 Million
- 4
No investor complaints pending or received during the period under review
Management Comments
Name not provided
The financial results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on 12th August 2025. The Statutory Auditors of the Company have expressed an unmodified opinion on these results.
Informational and educational content only. Not investment advice.